The U.S. Food and Drug Administration (FDA) has directed pharmaceutical companies Novo Nordisk and Eli Lilly to remove warnings regarding suicidal thoughts and behaviors...
Arrowhead Pharmaceuticals announced promising early results from its gene-silencing drug ARO-INHBE, which demonstrated significant fat loss in patients with obesity. In a Phase 1/2...